172 related articles for article (PubMed ID: 37642472)
1. Use of genomic markers to improve epidemiologic and clinical research in urology.
Cancel-Tassin G; Koutros S
Curr Opin Urol; 2023 Nov; 33(6):414-420. PubMed ID: 37642472
[TBL] [Abstract][Full Text] [Related]
2. Urine microRNAs as potential noninvasive biomarkers in urologic cancers.
Mlcochova H; Hezova R; Stanik M; Slaby O
Urol Oncol; 2014 Jan; 32(1):41.e1-9. PubMed ID: 24035473
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Role of RNA Expression Molecular Biomarkers in Prostate and Bladder Cancers.
Ahmed ME; Todenhöfer T; Karnes RJ; Seiler R
Eur Urol Focus; 2022 May; 8(3):663-666. PubMed ID: 35843864
[TBL] [Abstract][Full Text] [Related]
4. Intrinsic Molecular Subclassification of Urothelial Carcinoma of the Bladder: Are We Finally there?
Akhtar M; Al-Bozom IA; Ben Gashir M; Taha NM
Adv Anat Pathol; 2019 Jul; 26(4):251-256. PubMed ID: 31188799
[TBL] [Abstract][Full Text] [Related]
5. Emerging genomic biomarkers for improving kidney, prostate, and bladder cancer health disparities outcomes.
Mitchell KA; Williams H
Urol Oncol; 2022 Apr; 40(4):126-132. PubMed ID: 31239186
[TBL] [Abstract][Full Text] [Related]
6. Genomics in upper tract urothelial carcinoma.
Kammerer-Jacquet SF; Mathieu R; Peyronnet B; Rioux-Leclercq N; Bensalah K
Curr Opin Urol; 2017 Jan; 27(1):35-40. PubMed ID: 27584028
[TBL] [Abstract][Full Text] [Related]
7. Emerging critical role of molecular testing in diagnostic genitourinary pathology.
Netto GJ; Cheng L
Arch Pathol Lab Med; 2012 Apr; 136(4):372-90. PubMed ID: 22458900
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA in prostate, bladder, and kidney cancer.
Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
[TBL] [Abstract][Full Text] [Related]
9. Stem cells, biomarkers and genetic profiling: approaching future challenges in Urology.
Mancini M; Zazzara M; Zattoni F
Urologia; 2016; 83(1):4-13. PubMed ID: 26940971
[TBL] [Abstract][Full Text] [Related]
10. Germline prognostic markers for urinary bladder cancer: obstacles and opportunities.
Chang DW; Gu J; Wu X
Urol Oncol; 2012; 30(4):524-32. PubMed ID: 22742565
[TBL] [Abstract][Full Text] [Related]
11. Impact of automated data collection from urology offices: improving incidence and treatment reporting in urologic cancers.
Penberthy LT; McClish D; Agovino P
J Registry Manag; 2010; 37(4):141-7. PubMed ID: 21688743
[TBL] [Abstract][Full Text] [Related]
12. Genomic Markers in Prostate Cancer Decision Making.
Cucchiara V; Cooperberg MR; Dall'Era M; Lin DW; Montorsi F; Schalken JA; Evans CP
Eur Urol; 2018 Apr; 73(4):572-582. PubMed ID: 29129398
[TBL] [Abstract][Full Text] [Related]
13. The role of genetic markers in the management of prostate cancer.
Choudhury AD; Eeles R; Freedland SJ; Isaacs WB; Pomerantz MM; Schalken JA; Tammela TL; Visakorpi T
Eur Urol; 2012 Oct; 62(4):577-87. PubMed ID: 22695242
[TBL] [Abstract][Full Text] [Related]
14. Intratumour heterogeneity in urologic cancers: from molecular evidence to clinical implications.
Gerlinger M; Catto JW; Orntoft TF; Real FX; Zwarthoff EC; Swanton C
Eur Urol; 2015 Apr; 67(4):729-37. PubMed ID: 24836153
[TBL] [Abstract][Full Text] [Related]
15. [Optimizing treatment of advanced urologic malignancies].
Heidenreich A; Ohlmann CH; Ozgür E; Pfister D; Sahi D; Thüer D; Engelmann UH
Urologe A; 2007 Sep; 46(9):1278-84. PubMed ID: 17628781
[No Abstract] [Full Text] [Related]
16. Epidemiology of urothelial carcinoma.
Miyazaki J; Nishiyama H
Int J Urol; 2017 Oct; 24(10):730-734. PubMed ID: 28543959
[TBL] [Abstract][Full Text] [Related]
17. Global gene expression profiling identifies ALDH2, CCNE1 and SMAD3 as potential prognostic markers in upper tract urothelial carcinoma.
Wu S; Chen J; Dong P; Zhang S; He Y; Sun L; Zhu J; Cheng Y; Li X; Tang A; Huang Y; Gui Y; Liu C; Yang G; Zhou F; Cai Z; Wang R
BMC Cancer; 2014 Nov; 14():836. PubMed ID: 25408144
[TBL] [Abstract][Full Text] [Related]
18. [Multiple urologic tumors in autopsy material].
Tiszlavicz L; Szalay I
Orv Hetil; 1993 Mar; 134(11):577-81. PubMed ID: 8446411
[TBL] [Abstract][Full Text] [Related]
19. Global Burden of Urologic Cancers, 1990-2013.
Dy GW; Gore JL; Forouzanfar MH; Naghavi M; Fitzmaurice C
Eur Urol; 2017 Mar; 71(3):437-446. PubMed ID: 28029399
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Characterization of Common and Cancer-Specific Differently Expressed lncRNAs in Urologic Cancers.
Yan YJ; Zhang L; Zhou JJ; Chen ZJ; Liao YX; Zeng JM; Shen H
Comput Math Methods Med; 2021; 2021():5515218. PubMed ID: 34335862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
